Official EU label nameGlossary entry 560

ACETIC/LINOLEIC/PALMITIC TRIGLYCERIDE

This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.

Global evidence snapshot

The resolved identity has matching regulatory evidence in 0 of 13 indexed market datasets: 0 country records and 0 EU Annex records. Every result and evidence gap is listed below.

0 markets with evidence

Markets checked

Markets with evidence

Evidence gaps

Resolved identifiers

Resolved substance identity

CAS:221139-79-3

Ingredient index records:

ACETIC/LINOLEIC/PALMITIC TRIGLYCERIDE

Cosmetic functions: HUMECTANT, SKIN CONDITIONING, SKIN CONDITIONING - EMOLLIENT

9,12-Octadecadienoic acid (9Z,12Z)-, 1-[(acetyloxy)methyl]-2-[(1-oxohexadecyl)oxy]ethyl ester

Open full local profile

1 matched or reported name

ACETIC/LINOLEIC/PALMITIC TRIGLYCERIDE

Official name structure and source evidence

This section separates facts supplied by external records from structure derived only from the exact official label wording.

Structured interpretation of the official EU INCI label

Matchedlabel-analysis-v1 · EU 2025/1175

The official label is a composite INCI name with 3 named source-material segments. Each segment must be reconciled with the supplier specification.

Identity type inferred from wording: composite

Review 3 parsed source-name segments

ACETIC
LINOLEIC
PALMITIC TRIGLYCERIDE

This structure is derived only from the official label wording. It does not establish composition, concentration, chemical equivalence, safety or regulatory permission.

Open evidence source

Regulatory evidence across markets

None of the 13 markets tracked here holds an imported rule under the name ACETIC/LINOLEIC/PALMITIC TRIGLYCERIDE.

That is a statement about this inventory, not about the law: no imported rule is not evidence that a substance is permitted. A rule may exist under a different name, under a CAS or EC number this glossary entry does not carry, or in a dataset not yet imported.

Check the markets and their sources Search every market for this name

Chemical identity and properties

PubChem 2D chemical structure for CAS 221139-79-3

CAS 221139-79-3PubChem CID 53827958

Mosedipimod

Mosedipimod has been used in trials studying the supportive care and treatment of Chemotherapy-induced Neutropenia. — DrugBank

IUPAC name: (1-acetyloxy-3-hexadecanoyloxypropan-2-yl) octadeca-9,12-dienoate

Molecular formula: C39H70O6
Molecular weight: 635.0 g/mol
Exact mass: 634.51723995 Da
XLogP3: 14.1
Topological polar surface area: 78.9 Å²
Hydrogen-bond donors: 0
Hydrogen-bond acceptors: 6
Covalent units: 1
Defined stereocentres: 0

Also known as

mosedipimodumRefChem:819537acetylated diacylglycerol PLAGPLAG, (+-)1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG)1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol, acetylated diglyceride1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerolEc-18

1 more reported name

GTPL9771

Open full PubChem record PubChem annotations 3D structure image

External database identifiers

PubMed:32020584
PubMed:26655742
PubMed:25922599
PubMed:24269625
PubMed:19543512
PubMed:15256752
PubMed:14631148

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Additional authoritative substance research

Each link searches that source for this identity. A link is a research route, not a claim that the source holds an exact record. What each source is, and its legal weight

Cosmetic Ingredient Review safety assessments FDA Global Substance Registration System ILO/WHO International Chemical Safety Cards Japan NITE-CHRIP NIOSH Pocket Guide to Chemical Hazards OECD eChemPortal US EPA CompTox CTX APIs

Take this record further

Screen in a formula Open standalone comparison

Official source and scope

Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.

Open official Decision